These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6338850)

  • 21. Labetalol in hypertensive emergencies.
    MacCarthy EP; Frost GW; Stokes GS
    Med J Aust; 1978 Apr; 1(7):399-400. PubMed ID: 672732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of labetalol in experimental animals.
    Baum T; Sybertz EJ
    Am J Med; 1983 Oct; 75(4A):15-23. PubMed ID: 6314811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.
    Koch G
    Br Heart J; 1979 Feb; 41(2):192-8. PubMed ID: 106867
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Labetalol and other agents that block both alpha- and beta-adrenergic receptors.
    Pearce CJ; Wallin JD
    Cleve Clin J Med; 1994; 61(1):59-69; quiz 80-2. PubMed ID: 8124849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
    Hansson L; Hänel B
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
    Hansson L; Hänel B
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Labetalol in long-term treatment of hypertension.
    Prichard BN; Boakes AJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
    Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
    Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labetalol in resistant hypertension.
    Hedstrand H
    Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
    Adam WR; Meagher EJ; Barter CE
    Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinico-experimental study of the new antihypertensive preparation abletol (labetalol)].
    Glezer GA; Smolenskiĭ VS; Porotikov VI; Meĭler SM; Khodzhamirova VS
    Kardiologiia; 1983 Aug; 23(8):12-6. PubMed ID: 6137588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
    Steinrauf LK; Schulz AR; Ryder KW; Brunn PW; Cook D; Judy W
    Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
    [No Abstract]   [Full Text] [Related]  

  • 37. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 39. Labetalol in hypertension.
    Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.